80 related articles for article (PubMed ID: 17972515)
1. Lack of prognostic value of insulin-like growth factor-1 in patients with breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Chou FF; Hsu W; Huang CC; Eng HL; Tang RP
Anticancer Res; 2007; 27(5B):3541-4. PubMed ID: 17972515
[TBL] [Abstract][Full Text] [Related]
2. Signal transducer and activator of transcription 1 in breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Huang CC; Tang RP; Yang CH; Chou FF; Eng HL
Anticancer Res; 2007; 27(4B):2481-6. PubMed ID: 17695542
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-binding protein-3 in breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Zhang H; Huang CC; Tang RP
Anticancer Res; 2009 Apr; 29(4):1131-5. PubMed ID: 19414355
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of signal transducers and activators of transcription 3 in breast cancer.
Sheen-Chen SM; Huang CC; Tang RP; Chou FF; Eng HL
Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2286-90. PubMed ID: 18768494
[TBL] [Abstract][Full Text] [Related]
5. Lack of prognostic value of topoisomerase II alpha in patients with breast cancer: analysis with tissue microarray.
Sheen-Chen SM; Huang CY; Zhang H; Huang CC; Tang RP
Anticancer Res; 2010 Jun; 30(6):2459-62. PubMed ID: 20651408
[TBL] [Abstract][Full Text] [Related]
6. An evaluation of focal adhesion kinase in breast cancer by tissue microarrays.
Sheen-Chen SM; Huang CY; Chan YC; Tsai CH; Chi SY; Wu SC; Huang CC; Tang RP; Eng HL; Ko SF; Lee YW; Liang JL; Huang EY; Chen HC; Rau KM
Anticancer Res; 2013 Mar; 33(3):1169-73. PubMed ID: 23482798
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of hepatocyte growth factor in patients with breast cancer.
Sheen-Chen SM; Liu YW; Eng HL; Chou FF
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):715-7. PubMed ID: 15767355
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor co-activator (AIB1) protein expression by automated quantitative analysis (AQUA) in a breast cancer tissue microarray and association with patient outcome.
Harigopal M; Heymann J; Ghosh S; Anagnostou V; Camp RL; Rimm DL
Breast Cancer Res Treat; 2009 May; 115(1):77-85. PubMed ID: 18521745
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of prognostic value of death-associated protein kinase 1 in breast cancer.
Chou SE; Huang CY; Sheen-Chen SM; Liu YW; Tsai CH; Lin YH; Huang CC; Tang RP
Anticancer Res; 2011 Oct; 31(10):3633-6. PubMed ID: 21965790
[TBL] [Abstract][Full Text] [Related]
10. Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours.
Kornprat P; Rehak P; Rüschoff J; Langner C
J Clin Pathol; 2006 Feb; 59(2):202-6. PubMed ID: 16443739
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.
Law JH; Habibi G; Hu K; Masoudi H; Wang MY; Stratford AL; Park E; Gee JM; Finlay P; Jones HE; Nicholson RI; Carboni J; Gottardis M; Pollak M; Dunn SE
Cancer Res; 2008 Dec; 68(24):10238-46. PubMed ID: 19074892
[TBL] [Abstract][Full Text] [Related]
12. An evaluation of fatty acid-CoA ligase 4 in breast cancer.
Tsai CH; Sheen-Chen SM; Huang CY; Chen YJ; Chi SY; Ko SF; Lee YW; Liang JL; Hsu HW; Huang EY; Chen HC; Huang CC; Rau KM; Tang RP
Anticancer Res; 2014 Mar; 34(3):1239-43. PubMed ID: 24596366
[TBL] [Abstract][Full Text] [Related]
13. Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
Mu L; Katsaros D; Wiley A; Lu L; de la Longrais IA; Smith S; Khubchandani S; Sochirca O; Arisio R; Yu H
Breast Cancer Res Treat; 2009 May; 115(1):151-62. PubMed ID: 18481170
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of insulin-like growth factor 1 (IGF-I) and its receptor in mammary tissues and their associations with breast cancer survival.
Shin A; Ren Z; Shu XO; Cai Q; Gao YT; Zheng W
Breast Cancer Res Treat; 2007 Sep; 105(1):55-61. PubMed ID: 17066319
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
[TBL] [Abstract][Full Text] [Related]
16. Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer.
Arnes JB; Bégin LR; Stefansson I; Brunet JS; Nielsen TO; Foulkes WD; Akslen LA
J Clin Pathol; 2009 Feb; 62(2):139-46. PubMed ID: 18682421
[TBL] [Abstract][Full Text] [Related]
17. GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value.
Voduc D; Cheang M; Nielsen T
Cancer Epidemiol Biomarkers Prev; 2008 Feb; 17(2):365-73. PubMed ID: 18268121
[TBL] [Abstract][Full Text] [Related]
18. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
Voduc D; Nielsen TO; Cheang MC; Foulkes WD
Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
[TBL] [Abstract][Full Text] [Related]
19. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
[TBL] [Abstract][Full Text] [Related]
20. Circulating soluble Fas in patients with breast cancer.
Sheen-Chen SM; Chen HS; Eng HL; Chen WJ
World J Surg; 2003 Jan; 27(1):10-3. PubMed ID: 12557031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]